Trust Stamp Files Patent Application for Medical Diagnostic System
Gareth Genner, CEO of Trust Stamp commented, "Prior to this we had a total of twenty seven issued or allowed patents and seven patents pending, covering a range of proprietary technologies encompassing AI, Biometrics and cryptography. On June 15, 2026 we filed U.S. Provisional Patent Application No. 64/091,057 entitled: "Medical Diagnostic Assurance System" for an LLM-based technology designed to avoid critical issues in medical diagnosis including confirmation bias amplification, and hallucinations that could cite invented data sources. Sycophantic behavior can undermine the reliability of LLM outputs in any use case, but in medical diagnosis, the consequences can be catastrophic. MDAS is intended to operate as a self-contained sovereign system with tokenization of patient identities, thereby protecting patient records from third-party access, for use only by qualified medical practitioners. MDAS does not provide a primary diagnosis but, using a three-model consensus, challenges and/or reinforces the medical practitioner's diagnosis using data flows that ensure that the model's research is conducted blind to that original diagnosis. We are currently negotiating a pilot program for MDAS and aim to have the technology live in Q1 of 2027."
